It was reported that on (b)(6) 2002, a 21mm masters series heart valve with teflon cuff was successfully implanted in a patient's aortic valve.In (b)(6) 2023, the patient had a medical examination and the patient displayed symptoms of aortic stenosis: shortness of breath/dyspnea on exertion.An echocardiogram (echo) was performed, and mild-moderate aortic stenosis was confirmed.In may, the aortic stenosis progressed, and it was decided that valve replacement was necessary.On (b)(6) 2023, the device was explanted and a 19mm epic valve was implanted.Pannus was seen circumferentially on the inflow side of the masters valve, which indicated that the valve was not completely opening.The patient was reported as stable.
|
An event of stenosis 21 years after the masters valve was implanted resulting in explant of the valve was reported.The valve was received for examination and no pannus or tissue was noted on the valve.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Information from the field indicated that there was no change in appearance noted on the valve at explant and that the problem was not with the valve.The reported pannus on the inflow side of the valve could have contributed to the stenosis and incomplete coaptation reported.There is no indication of a product quality issue with regards to manufacture, design, or labeling.
|